1. PMO-157 HBSAG plasma levels decline helps to predict HBEAG loss but is similar in different NUCLEOS(T)IDE analogues regimens. (28th May 2012) Authors: Horner, M; Bruce, M J; Knighton, S; Al-Freah, M; Joshi, D; Hughes, S; Suddle, A; Harrison, P M; Agarwal, K; Carey, I Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PWE-009 Evaluation of out-of-hours emergency endoscopy outcomes at a large liver and gastrointestinal centre. (22nd June 2015) Authors: Hawken, J; Audimoolam, V; Hayee, B; Dubois, P; Chung-Faye, G; Bjarnason, I; Devlin, J; Harrison, P; Heneghan, M; Agarwal, K; Suddle, A Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTH-110 Long term survival following treatment for hepatocellular carcinoma in patients with hereditary haemochromatosis. (22nd June 2015) Authors: Mcphail, M; Abbott, L; Al-Kadhimi, G; Kane, P; Karani, J; Heaton, N; O'Grady, J; Bomford, A; Suddle, A Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PTH-121 Transarterial chemoembolisation at king's – a comparison of conventional tace vs tace with beads in clinical practice. (22nd June 2015) Authors: Pennycuick, A; McPhail, M; Considine, A; O'Grady, N. Heaton, J; Suddle, A Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P47 De-novo antiviral therapy with nucleos(t)ide analogues in 'real-life' patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy. (6th September 2011) Authors: Carey, I; Nguyen DorothyJoe, H; Al-Freah, M; Knighton, S; Bruce, M; Suddle, A; Harrison, P M; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P60 Pre-treatment IP-10 concentrations are associated with a sustained virological response in HIV/HCV co-infected patients. (6th September 2011) Authors: Joshi, D; Bruce, M; Suddle, A; Taylor, C; Carey, I; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P34 No effect of tenofovir or entecavir on vitamin D levels in Chronic Hepatitis B mono-infected patients. Single centre 'real life' cohort experience. (6th September 2011) Authors: Nguyen, H-L; Carey, ; Al-Freah, M A B; Joe, D; Sherwood, R; Knighton, S; Harrison, P; Suddle, A; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P77 A Pharmacist delivered stratified conversion protocol from Hepatitis B Immunoglobulin (HBIG) to tenofovir or entecavir is efficacious, safe and cost-effective for prevention of recurrence of Hepatitis B virus (HBV) in Liver Transplant (LT) recipients. (6th September 2011) Authors: Knighton, S; Agarwal, K; Heneghan, M; O'Grady, J; Bruce, M; Carey, I; Heaton, N; Suddle, A Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P67 Switch to other nucleos(t)ide analogues therapy in chronic hepatitis B cohort on long-term de-novo combination therapy with lamivudine plus adefovir: efficacy and safety. (6th September 2011) Authors: Carey, I; Mendes, A; Joshi, D; Bruce, M; Knighton, S; Scalori, A; Hughes, S; Al-Freah, M; Suddle, A; Harrison, P M; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P69 Hepatitis delta RNA level and genotype, and hepatitis B surface antigen titre predict response to PEG-interferon in the treatment of chronic hepatitis delta virus. (16th November 2010) Authors: Hughes, S; Carey, I; Shang, D; Horner, M; Bruce, M; Fletcher, I; Cross, T J S; Suddle, A; Agarwal, K; Harrison, P M Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗